TAG:
the clinical laboratory
Lab Venture in Houston To Include a New Partner
By Robert Michel | From the Volume VI No. 14 – October 11, 1999 Issue
CEO SUMMARY: For months, lab industry rumors said the Memorial-Hermann merger had killed the Dynacare-Hermann Hospital laboratory joint venture, despite its sustained profitability. Now comes news that the Memorial Hermann Healthcare System and Dynacare will expand the laboratory joint ve…
Revamped Houston JV Validates Industry Trend
By Robert Michel | From the Volume VI No. 14 – October 11, 1999 Issue
CEO SUMMARY: Change is notoriously slow in both the hospital and the clinical laboratory industry. The announcement of a revamped laboratory joint venture between Houston’s Memorial Hermann Healthcare System and Dynacare demonstrates that market pressures continue to encourage the ratio…
Pap Smear Marketplace Shifting into High Gear
By Robert Michel | From the Volume VI No. 14 – October 11, 1999 Issue
CEO SUMMARY: It took just four years to shake out the weakest competitors in the emerging field of automated cytology. Now only TriPath Imaging, Inc. and Cytyc Corporation remain in competition. Indications are that this will be a nasty battle. Pathologists and lab executives contemplatin…
Big Challenges For Clinical Laboratories
By R. Lewis Dark | From the Volume VI No. 15 – November 1, 1999 Issue
AS YOU WILL READ IN THIS ISSUE, IT IS A REMARKABLE PREDICTION. Our editor states that, in only 24 months, virtually every physicians office in the United States will be connected to its laboratory providers through a web-based arrangement. In my decades of watching the clinical laboratory industry, …
Finally: Respect for Cytyc As Aetna OKs ThinPrep®
By Robert Michel | From the Volume VI No. 13 – September 20, 1999 Issue
CEO SUMMARY: Here’s an important development in the battle to get the healthcare community to accept new technology for the preparation of Pap smears. Aetna/U.S. Healthcare announced that it would cover the monolayer preparation tests offered by Cytyc and AutoCyte. Aetna’s decision ma…
Ten Management Myths Misled Clinical Laboratory Executives
By Robert Michel | From the Volume VI No. 13 – September 20, 1999 Issue
CEO SUMMARY: We offer our second installment about the ten management myths which led the clinical laboratory industry astray during the 1980s and 1990s. Regretfully, clients responding to part one of this series tell us that these management myths remain alive and well—and continue to …
Pathologist Income Symposium, Healtheon, Biogenetics, Healthworks Alliance
By Robert Michel | From the Volume VI No. 13 – September 20, 1999 Issue
PATHOLOGIST INCOME SYMPOSIUM DATES ARE NOVEMBER 12-13, 1999 SCOTTSDALE IS AGAIN SLATED TO HOST the upcoming private Pathologist Income Symposium, scheduled for November 12-13, 1999. This year’s symposium tackles the toughest of all topics: increasing the compensation paid by hosp…
Bankruptcy at Universal Standard Brings End to Detroit Laboratory
By Robert Michel | From the Volume VI No. 12 – August 30, 1999 Issue
ANOTHER OF THE EARLY 1990’S wunderkind laboratory companies is now defunct. On August 13, Universal Standard Healthcare, Inc. (UHCI) filed a Chapter 7 Bankruptcy action in federal court and ceased business operations. Headquartered in Southfield, Michigan, Universal Standard was o…
Ten Myths of Lab Management That Led the Clinical Lab Industry Astray
By Robert Michel | From the Volume VI No. 11 – August 9, 1999 Issue
Part One of a Special Series CEO SUMMARY: One of our most popular series ever was the “13 Perilous Parallels” of laboratory management. This four-part story appeared in 1996 and chronicled similar management strategies used by various national laboratories during the…
Quest and SBCL Expect Merger Date Of July 2
By Robert Michel | From the Volume VI No. 9 – June 28, 1999 Issue
CEO SUMMARY: After months of waiting and planning, executives at Quest Diagnostics Incorporated believe that July 2, 1999 will be the date when their acquisition of SmithKline Beecham Clinical Laboratories becomes official. During the month of July, expect a flurry of activity at Quest Di…
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized